Her expertise lies in qualitative methods and the social sciences of hepatitis C and harm reduction. She has been based at LSHTM since 2009, where she conducts a programme of research investigating the lived experience of hepatitis C, its treatment and prevention in the UK. Magdalena is a former recipient of an NIHR Post-Doctoral Fellowship (‘The Hepatitis C Treatment Journey’) and currently holds an NIHR Career Development Fellowship (‘Care and Prevent’). This mixed-method project extends beyond a focus on hepatitis C and qualitative methods. It is the first study in the UK to investigate the barriers and facilitators to skin and soft tissue infection (SSTI) care for people who inject drugs, and the first globally to explore the potential of urine screening in drug treatment settings for preventing SSTI-related kidney failure (AA amyloidosis).